Charming Medical Limited (MCTA)
NASDAQ: MCTA · Real-Time Price · USD
29.11
-0.25 (-0.83%)
Nov 11, 2025, 4:00 PM EDT - Market closed
Charming Medical Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Cash & Equivalents | 4.7 | 0.82 | 2.1 | 1.93 |
Short-Term Investments | 2.46 | 1.62 | 0.3 | - |
Trading Asset Securities | 0.51 | 0.5 | - | - |
Cash & Short-Term Investments | 7.68 | 2.94 | 2.4 | 1.93 |
Cash Growth | 160.79% | 22.69% | 24.34% | - |
Accounts Receivable | 0.2 | 0.4 | 0.35 | 0.19 |
Other Receivables | 0 | 0 | 0 | 1.82 |
Receivables | 0.2 | 0.4 | 0.36 | 2 |
Inventory | 0.03 | 0.03 | 0.03 | 0.07 |
Prepaid Expenses | - | - | - | 0.02 |
Other Current Assets | 0.27 | - | 0.89 | 0.1 |
Total Current Assets | 8.17 | 3.37 | 3.67 | 4.12 |
Property, Plant & Equipment | 1.33 | 1.21 | 0.92 | 1.8 |
Long-Term Deferred Tax Assets | 0.01 | 0.08 | 0.21 | 0.27 |
Long-Term Deferred Charges | - | 0.57 | 0.03 | - |
Other Long-Term Assets | 0.35 | 0.13 | 0.05 | 0.19 |
Total Assets | 9.87 | 5.36 | 4.88 | 6.38 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Accounts Payable | 0.03 | 0.22 | - | 0 |
Accrued Expenses | 0.36 | 0.21 | 0.41 | 0.23 |
Short-Term Debt | 0.19 | 0.31 | 0.44 | 0.59 |
Current Portion of Leases | 0.37 | 0.49 | 0.37 | 0.74 |
Current Income Taxes Payable | 0.31 | 0.22 | 0.12 | - |
Current Unearned Revenue | 3.05 | 3.46 | 4.5 | 5.6 |
Other Current Liabilities | 0.03 | 0.04 | 0.04 | 0.01 |
Total Current Liabilities | 4.33 | 4.95 | 5.88 | 7.17 |
Long-Term Leases | 0.36 | 0.36 | 0.15 | 0.48 |
Total Liabilities | 4.69 | 5.31 | 6.03 | 7.65 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Common Stock | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 5.1 | 0.31 | 0.38 | 0.38 |
Retained Earnings | 0.1 | 0.12 | -1.08 | -1.16 |
Comprehensive Income & Other | -0.01 | -0.38 | -0.38 | -0.38 |
Total Common Equity | 5.18 | 0.05 | -1.08 | -1.16 |
Minority Interest | - | - | -0.07 | -0.11 |
Shareholders' Equity | 5.18 | 0.05 | -1.15 | -1.27 |
Total Liabilities & Equity | 9.87 | 5.36 | 4.88 | 6.38 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Total Debt | 0.91 | 1.16 | 0.96 | 1.81 |
Net Cash (Debt) | 6.77 | 1.78 | 1.44 | 0.12 |
Net Cash Growth | 279.67% | 24.01% | 1100.97% | - |
Net Cash Per Share | 0.42 | 0.12 | 0.09 | 0.01 |
Filing Date Shares Outstanding | 17.18 | 15.34 | 15.34 | 15.34 |
Total Common Shares Outstanding | 17.18 | 15.34 | 15.34 | 15.34 |
Working Capital | 3.84 | -1.58 | -2.21 | -3.05 |
Book Value Per Share | 0.30 | 0.00 | -0.07 | -0.08 |
Tangible Book Value | 5.18 | 0.05 | -1.08 | -1.16 |
Tangible Book Value Per Share | 0.30 | 0.00 | -0.07 | -0.08 |
Machinery | 0.92 | 0.66 | 0.37 | 0.2 |
Leasehold Improvements | 0.53 | 0.72 | 0.8 | 0.75 |